STOCK ALARM
SA
Menu
Demo
Log In
PLX
(PLX)
PLX
Overview
Notebook
Intelligence
Chart
History
Fundmntls
TTM
Earnings
Analysts
News
Financials
Segments
Insiders
Institl.
DCF
Peers
Trailing Twelve Months (TTM) Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
Home
Screener
Alerts
Search
More
Protalix BioTherapeutics, Inc.
(PLX)
$2.44
▲
0.07 (2.95%)
Chart
Share
Post on X
PLX
Protalix BioTherapeutics, Inc.
(PLX)
NYSE
$2.44
▲
0.07 (2.95%)
Chart Studio
Share
PLX
Per Share (TTM)
Revenue/Share
$0.96
Net Income/Share
$0.19
Operating CF/Share
$0.19
Free CF/Share
$0.16
Cash/Share
$0.65
Book Value/Share
$0.84
Tangible Book/Share
$0.84
Equity/Share
$0.84
Interest Debt/Share
$0.13
CapEx/Share
$0.03
Dividend/Share
$0.00
Valuation
Market Cap
$196.59M
Enterprise Value
$163.36M
P/E Ratio
12.64
P/S Ratio
2.57
P/OCF Ratio
12.91
P/FCF Ratio
15.13
P/B Ratio
2.90
P/TB Ratio
2.90
EV/Sales
2.14
EV/EBITDA
7.32
Graham Valuation
Graham Number
$1.91
Graham Net-Net
$0.43
Profitability
Earnings Yield
7.87%
FCF Yield
6.61%
ROE
28.10%
ROIC
20.62%
Return on Tangible Assets
14.98%
Dividend
Dividend Yield
0.00%
Payout Ratio
0.00%
Capital Allocation
CapEx/OCF
13.87%
CapEx/Revenue
2.74%
CapEx/Depreciation
1.37
SBC/Revenue
3.00%
SG&A/Revenue
15.88%
R&D/Revenue
28.17%
Liquidity & Solvency
Debt/Equity
0.13
Debt/Assets
0.08
Debt/Market Cap
0.04
Net Debt/EBITDA
-1.49
Current Ratio
3.15
Interest Coverage
12.86x
Income Quality
0.98
Efficiency
Days Sales Outstanding
14 days
Days Payables Outstanding
68 days
Days Inventory
485 days
Receivables Turnover
25.99x
Payables Turnover
5.35x
Inventory Turnover
0.75x
Capital Structure
Tangible Assets
$67.23M
Working Capital
$58.97M
Invested Capital
$71.91M
Intangibles/Assets
0.00%